---
figid: PMC12059070__41467_2025_59505_Fig7_HTML
figtitle: Gemcitabine-induced cellular responses
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12059070
filename: 41467_2025_59505_Fig7_HTML.jpg
figlink: /pmc/articles/PMC12059070/figure/F7/
number: F7
caption: Schematic summary of gemcitabine-induced cellular responses in sensitive
  (red nodes) versus resistant (green nodes), or both (orange nodes) cells. Dotted
  line indicates signaling pathway yet to be established in detail. Created in BioRender.
  Tam, W. (2025) https://BioRender.com/jgju7ac
papertitle: MS CETSA deep functional proteomics uncovers DNA repair programs leading
  to gemcitabine resistance
reftext: Ying Yu Liang, et al. Nat Commun. 2025;16(NA).
year: '2025'
doi: 10.1038/s41467-025-59505-8
journal_title: Nature Communications
journal_nlm_ta: Nat Commun
publisher_name: Nature Publishing Group
keywords: DNA damage and repair | Protein-protein interaction networks
automl_pathway: 0.9255197
figid_alias: PMC12059070__F7
figtype: Figure
redirect_from: /figures/PMC12059070__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12059070__41467_2025_59505_Fig7_HTML.html
  '@type': Dataset
  description: Schematic summary of gemcitabine-induced cellular responses in sensitive
    (red nodes) versus resistant (green nodes), or both (orange nodes) cells. Dotted
    line indicates signaling pathway yet to be established in detail. Created in BioRender.
    Tam, W. (2025) https://BioRender.com/jgju7ac
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - RRM1
  - CHEK1
  - RPA1
  - POLR1A
  - RPA2
  - POLR1B
  - RPA3
  - DNMT1
  - RB1
  - RBM45
  - ATR
  - ANTXR1
  - MMAB
  - SERPINA2
  - CDK1
  - CCNB1
  - CCNA2
  - CCNB2
  - PARP1
  - MATR3
  - FUS
  - LMNB1
  - DDX21
  - DDX56
  - POLD2
  - PCLAF
  - POLD1
  - POLD4
  - POLDIP2
  - DTL
  - TNFSF13B
  - RRM2
  - TK1
  - GMNN
  - SLBP
  - FBXO5
  - Gemcitabine
  - DTL
---
